ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 181

Functional and Quantitative Changes of CCR6+ type3 Innate Lymphoid Cells in Murine Collagen-Induced Arthritis

Ayako Takaki1, Yojiro Arinobu1, Kensuke Irino1, Hirofumi Tsuzuki1, Yuri Ota1, Daisuke Oroji1, Masahiro Ayano1, Yashitaka Kimoto2, Hiroki Mitoma1, Mitsuteru Akahoshi1, Hiroaki Niro1, Hiroshi Tsukamoto1, Takahiko Horiuchi2 and Koichi Akashi1, 1Department of medicine and biosystemic science, Kyushu University Hospital, Fukuoka, Japan, 2Department of internal medicine, Kyushu University Beppu Hospital, Beppu, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Animal models, innate immunity and rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Innate Immunity and Rheumatic Disease - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Innate lymphoid cells (ILCs) are a group of lymphocytes that lack antigen-specific receptors and have important roles in mediating immune responses and in regulating tissue homeostasis. ILCs are classified into three subsets, ILCs 1, 2, and 3, based on their patterns of cytokine production and transcription factors (TFs) expression. ILC3s are dependent on Retinoic-acid-receptor-relates orphan receptorγt (RORγt) and produce cytokines such as IL-17, IL-22, and Tumor necrosis factor -α (TNF-α), which play critical roles in inflammatory arthritis. ILC3s are further subdivided into several populations based on the expression of surface markers. LTi cells, which express chemokine receptor 6 (CCR6), are important for development and maintenance of lymph nodes and secondary lymphoid tissues. Another subgroup is natural cytotoxicity receptor (NCR) + ILC3s, which are essential for the epithelial barrier and host protection in the intestine. In rheumatic diseases, the increase of the number of NCR+ ILC3s was reported in patients with psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS). It has also been shown that CCR6+ILC3s have increased in synovium fluid (SF) of patients with PsA. In this study, we tried to evaluate the ILCs 1,2, and 3 both in quantity and quality in various tissues isolated from collagen induced arthritis (CIA) model mice in order to clarify the role of ILCs in the development of rheumatoid arthritis (RA).

Methods: We isolated lymphocytes from bone marrow (BM), spleen, peripheral blood (PB), local lymph nodes (LNs) and joints in normal and CIA model mice. ILC1s, ILC2s, CCR6+ILC3s and NCR+ILC3s were determined by flow cytometry using surface markers, NK1.1 (ILC1), IL-33R (ILC2), CCR6 and NKp46 (ILC3). Gene expression of the TFs and cytokines were­­ measured by quantitative real-time PCR (qPCR) to confirm that ILC subsets are precisely classified by these surface markers. Finally, we compared the absolute cell number, ratio, gene expressions of TFs and cytokines of each ILC sunset in normal and in CIA model mice.

 

Results: CCR6+ILC3s showed high gene expression of RORγt, IL-17, IL-22 and TNF-α as reported previously. In CIA model mouse, in addition to the increase of ratio of CCR6+ILC3s in PB and joints, the levels of gene expression of TFs and cytokines were significantly elevated. Almost all of NKp46+ILC3s expressed NK1.1, which is a marker for ILC1s. NKp46+ILC3s showed lower gene expression of RORγt, IL-17 and IL22 than CCR6+ILC3, while they showed high gene expression of T-bet and Interferon-γ(IFN-γ), suggesting that NKp46+ ILC3s in our purification method may include a fraction of ILC1s. Another marker which can further subdivide NKp46+ILC3 population is required. 

Conclusion: CCR6+ILC3 produce IL-17, IL-22 and TNF-α, which are essential cytokines for the development of CIA. CCR6+ILC3s may play roles in pathogenesis of RA through its production of cytokines.


Disclosure: A. Takaki, None; Y. Arinobu, None; K. Irino, None; H. Tsuzuki, None; Y. Ota, None; D. Oroji, None; M. Ayano, None; Y. Kimoto, None; H. Mitoma, None; M. Akahoshi, None; H. Niro, None; H. Tsukamoto, None; T. Horiuchi, None; K. Akashi, None.

To cite this abstract in AMA style:

Takaki A, Arinobu Y, Irino K, Tsuzuki H, Ota Y, Oroji D, Ayano M, Kimoto Y, Mitoma H, Akahoshi M, Niro H, Tsukamoto H, Horiuchi T, Akashi K. Functional and Quantitative Changes of CCR6+ type3 Innate Lymphoid Cells in Murine Collagen-Induced Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/functional-and-quantitative-changes-of-ccr6-type3-innate-lymphoid-cells-in-murine-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-and-quantitative-changes-of-ccr6-type3-innate-lymphoid-cells-in-murine-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology